Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-23-007308

Options or other derivatives

  • General Counsel/Secretary acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Samuel George A. III General Counsel/Secretary 2023-03-09 Grant or award · Employee Stock Option (Right to Buy) +650,000 650,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…